Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts

American Journal of Cardiology

Volumn 80, Issue 8, 1997, Pages 985-988

  Mak, Koon Hou ^b   Challapalli, Ram ^b   Eisenberg, Mark J ^b   Anderson, Keaven M ^b   Califf, Robert M ^b   Topol, Eric J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EMBOLISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; Q WAVE; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; SAPHENOUS VEIN; VEIN GRAFT;

AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; ATHERECTOMY, CORONARY; CHEMOTHERAPY, ADJUVANT; CORONARY ARTERY BYPASS; CORONARY DISEASE; EMBOLISM; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SAPHENOUS VEIN;

EID: 0030704744     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00589-4     Document Type: Article

References (18)

1. Douglas JS. Percutaneous intervention in patients with prior coronary bypass surgery. In: Topol EJ, ed. Textbook of Interventional Cardiology. Philadelphia, PA: WB Saunders, 1994:339-354.
2. Walts AE, Fishbein MC, Sustaite H, Matloff JM. Ruptured atheromatous plaques in saphenous vein coronary bypass grafts: a mechanism of acute, thrombotic, late graft occlusion. Circulation 1982;65:197-201.
3. Mautner SL, Mautner GC, Hunsbarger SA, Roberts WC. Comparison of composition of atherosclerotic plaques in saphenous veins used as aortocoronary bypass conduits with plaques in native coronary artery in the same men. Am J Cardiol 1992;70:1380-1387.
4. Platko WP, Hollman J, Whitlow PL, Franco I. Percutaneous transluminal angioplasty of saphenous vein graft stenosis: long-term follow-up. J Am Coll Cardiol 1989;14:1645-1650.
5. Abdelmeguid AE, Topol EJ. The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures. Circulation 1996;94: 3369-3375.
6. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
7. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, for the TIMI Investigators. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue-plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987;76:142-154.
8. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, for the EPIC Investigators. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 1994;343:881-886.
9. Keon WJ, Heggtveit HA, Leduc J. Perioperative myocardial infarction caused by atheroembolism. J Cardiovasc Surg 1982;84:849-855.
10. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995;332:1553-1559
11. Holmes DR Jr, Topol EJ, Califf RM, Berdan LG, Leya F, Berger PB, Whitlow PL, Safian RD, Adelman AG, Kellett MA Jr, for the CAVEAT-II Investigators. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. Circulation 1995;91:1966-1974.
12. Lefkovits J, Holmes DR Jr, Califf RM, Safian RD, Pieper K, Keeler G, Topol EJ. Predictors and sequelae of distal embolization during sapheonous vein graft intervention from the CAVEAT-II trial. Circulation 1995;92:734-740.
13. Neitzel GF, Barboriak JJ, Pintar K. Atherosclerosis in aortocoronary bypass grafts. Morphologic study and risk factor analysis 6 to 12 years after surgery. Arteriosclerosis 1986;6:594-600.
14. Leon MB, Wong SC, Pichard AD. Balloon-expandable stent implantation in saphenous vein grafts. In: Hermann HC, Hirschfeld JW, eds. Clinical Use of the Palmaz-Schatz Intracoronary Stent. Mt Kisco, NY: Futura, 1993:111-121.
15. de Scheerder IK, Strauss BH, de Feyter PJ, Beatt KJ, Baur LH, Wijins W, Heyndrix GR, Suryapranata H, van den Brand M, Buis B. Stenting of venous grafts: a new treatment modality for patients who are poor candidates for reintervention. Am Heart J 1992;123:1046-1054.
16. Strumpf RK, Mehta SS, Ponder R, Heuser RR. Palmaz-Schatz stent implantation in stenosed saphenous vein grafts: clinical and angiographic follow-up. Am Heart J 1992;123:1329-1336.
17. Safian RD, Grines CL, May MA, Litchtenberg A, Juran N, Schreiber TL, Pavlides G, Meany TB, Savas V, O'Neil WW. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. Circulation 1994;89:302-312.
18. Hong MK, Popma JJ, Pichard AD, Kent KM, Salter LF, Chuang YC, Mintz GS, Keller MB, Leon MB. Clinical significance of distal embolization after transluminal extraction atherectomy in saphenous vein grafts. Am Heart J 1994; 127:1496-1503.